These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32589342)

  • 21. Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa.
    McGrath N; Lessells RJ; Newell ML
    HIV Med; 2015 Sep; 16(8):512-8. PubMed ID: 25959724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fee for home delivery and monitoring of antiretroviral therapy for HIV infection compared with standard clinic-based services in South Africa: a randomised controlled trial.
    Barnabas RV; Szpiro AA; Ntinga X; Mugambi ML; van Rooyen H; Bruce A; Joseph P; Ngubane T; Krows ML; Schaafsma TT; Zhao T; Tanser F; Baeten JM; Celum C; van Heerden A;
    Lancet HIV; 2022 Dec; 9(12):e848-e856. PubMed ID: 36335976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief Report: Financial Incentives and Real-Time Adherence Monitoring to Promote Daily Adherence to HIV Treatment and Viral Suppression Among People Living With HIV: A Pilot Study.
    Bien-Gund CH; Ho JI; Bair EF; Marcus N; Choi RJ; Szep Z; Althoff A; Momplaisir FM; Thirumurthy H
    J Acquir Immune Defic Syndr; 2021 May; 87(1):688-692. PubMed ID: 33470727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.
    Labhardt ND; Ringera I; Lejone TI; Klimkait T; Muhairwe J; Amstutz A; Glass TR
    JAMA; 2018 Mar; 319(11):1103-1112. PubMed ID: 29509839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Findings from home-based HIV testing and facilitated linkage after scale-up of test and treat in rural South Africa: young people still missing.
    Baisley KJ; Seeley J; Siedner MJ; Koole K; Matthews P; Tanser F; Bärnighausen T; Smit T; Gareta D; Dlamini S; Herbst K; Hm Y; Cc I; Hy K; D P; M S
    HIV Med; 2019 Nov; 20(10):704-708. PubMed ID: 31454139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioral intervention grounded in motivational interviewing and behavioral economics shows promise with Black and English-speaking Latino persons living with HIV with unsuppressed HIV viral load in New York City: A mixed methods pilot study.
    Gwadz M; Serrano S; Linnemayr S; Cleland CM; Cluesman SR; Freeman RM; Kellam K; De Stefano C; Israel K; Pan E
    Front Public Health; 2022; 10():916224. PubMed ID: 36187648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing and Predictors of Initiation on Antiretroviral Therapy Among Newly-Diagnosed HIV-Infected Persons in South Africa.
    Larsen A; Cheyip M; Tesfay A; Vranken P; Fomundam H; Wutoh A; Aynalem G
    AIDS Behav; 2019 Feb; 23(2):375-385. PubMed ID: 30008050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of financial incentives on viral suppression among adults initiating HIV treatment in Tanzania: a hybrid effectiveness-implementation trial.
    Njau PF; Katabaro E; Winters S; Sabasaba A; Hassan K; Joseph B; Maila H; Msasa J; Fahey CA; Packel L; Dow WH; Jewell NP; Ulenga N; Mwenda N; McCoy SI
    Lancet HIV; 2024 Sep; 11(9):e586-e597. PubMed ID: 39098325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
    Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
    AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South Africa.
    Haber N; Tanser F; Bor J; Naidu K; Mutevedzi T; Herbst K; Porter K; Pillay D; Bärnighausen T
    Lancet HIV; 2017 May; 4(5):e223-e230. PubMed ID: 28153470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Home-Based Intervention to Test and Start (HITS): a community-randomized controlled trial to increase HIV testing uptake among men in rural South Africa.
    Tanser FC; Kim HY; Mathenjwa T; Shahmanesh M; Seeley J; Matthews P; Wyke S; McGrath N; Adeagbo O; Sartorius B; Yapa HM; Zuma T; Zeitlin A; Blandford A; Dobra A; Bärnighausen T
    J Int AIDS Soc; 2021 Feb; 24(2):e25665. PubMed ID: 33586911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal trends of population viral suppression in the context of Universal Test and Treat: the ANRS 12249 TasP trial in rural South Africa.
    Larmarange J; Diallo MH; McGrath N; Iwuji C; Plazy M; Thiébaut R; Tanser F; Bärnighausen T; Orne-Gliemann J; Pillay D; Dabis F;
    J Int AIDS Soc; 2019 Oct; 22(10):e25402. PubMed ID: 31637821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
    Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
    PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the test and treat policy on delays in antiretroviral therapy initiation among adult HIV positive patients from six clinics in Johannesburg, South Africa: results from a prospective cohort study.
    Onoya D; Sineke T; Hendrickson C; Mokhele I; Maskew M; Long LC; Fox M
    BMJ Open; 2020 Mar; 10(3):e030228. PubMed ID: 32213514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conditional economic incentives and motivational interviewing to improve adolescents' retention in HIV care and adherence to antiretroviral therapy in Southeast Nigeria: study protocol for a cluster randomised trial.
    Ekwunife OI; Anetoh MU; Kalu SO; Ele PU; Eleje GU
    Trials; 2018 Dec; 19(1):710. PubMed ID: 30594223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study.
    Sy KTL; Tariq S; Ramjee G; Blanchard K; Leu CS; Kelvin EA; Exner TM; Gandhi AD; Lince-Deroche N; Mantell JE; O'Sullivan LF; Hoffman S
    PLoS One; 2021; 16(2):e0246744. PubMed ID: 33606712
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.